Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals obtained the approval and launch of Andexxa.

2 documented relationships

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Mr. KoenigEmploymentPortola Pharmaceuticals, Inc.
2019 · 2020Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Role or object indicated by the source: “Executive Vice President and Chief Commercial Officer”.
AlexionOwnershipPortola Pharmaceuticals, Inc.
Amount not specifiedAugust 2020Reported^{1Leadership Team | Esperion Therapeutics, Inc.esperion.com}
Role or object indicated by the source: “acquired”.

Sources

1.
Leadership Team | Esperion Therapeutics, Inc.
Web pageesperion.com
View original ↑ Back to text